期刊文献+

EZH2在大肠癌中的表达及其临床意义 被引量:1

The expression and clinic significance of EZH2 protein in primary human Colorectal carcinoma
下载PDF
导出
摘要 目的:探讨果蝇zeste基因增强子同源物2(EZH2)蛋白在大肠癌中的表达状况及其临床意义。方法:应用免疫组化S-P法检测大肠癌60例、正常大肠组织10例中EZH2蛋白的表达。结果:EZH2蛋白主要表达于细胞核。大肠癌、正常大肠组织的EZH2蛋白阳性表达率分别是71.7%(44/50)、0.0%(0/10),EZH2蛋白在大肠癌组织中的表达明显高于在正常大肠组织中的表达(χ2=15.68,P<0.01),且EZH2蛋白在大肠癌中的表达与性别、年龄、分化程度、临床分期、大体分型、癌肿大小有关。结论:EZH2异常表达与大肠癌的发展密切相关,在大肠癌的发展过程中起重要的作用。 Objective:To explore the expression and clinic significance of EZH2 (enhancer of zeste homolog 2 ) protein in human colorectal carcinoma. Methods : The expressions of EZH2 protein in 60 colorectal carcinoma tissues, 10 normal tissues were assessed by method. Results:The expressions of EZH2 protein was located at nucleus The rate of expressions of EZH2 protein in cancer tissues, normal tissues were 71.7% (44/50) ,0.0% (0/10) respectively. The expressions of EZH2 protein in cancer tissues was higher than that in normal tissues( χ^2 = 15.68 ,P 〈0.01 ). The expressions of EZH2 protein in cancer tissues was correlated with the tumor size,sex,differentiation,clinical stage, typing,tumor size. Conclusion:The abnormal expression of EZH2 are closely associated with the development of human colorectal carcinoma,which may play an important role in the development of primary human colorectal carcinoma.
出处 《赣南医学院学报》 2010年第3期369-371,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 大肠癌 EZH2 免疫组化 colorectal carcinoma EZH2 immunohistochemistry
  • 相关文献

参考文献10

  • 1Kheradmand Kia S,Solaimani Kartalaei P,Farahbakhshian E,et al.EZH2-dependent chromatin looping controls INK4a and INK4b,but not ARF,during human progenitor cell differentiation and cellular senescence[J].Epigenetics Chromatin,2009,2(1):16.
  • 2Hobert O,J allal B,Ulrich A.Interaction of Vav with ENX-1,a putative transcriptional regulator of homeobox gene expression[J].MCB,1996,16(6):3066-3073.
  • 3Carlos Cardoso,Cecile Mignon,Giles Hetet,et al.The human EZH2 gene:geno-mic organisatin and revised mapping in 7q35 within the criticat region for malignan t myeloid disorders[J].Eur J Hum Genetics,2000,8(3):174-180.
  • 4Chen H,Rossier C,Antonarakis SE.Cloning of a human homolog of the drosophila enhancer of seste gene(EZH2) that maps to chromosome 21q22.2[J].Genomies,2008,38(1):30-37.
  • 5Yoon KA,Gil H J,Han J,et al.Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer[J].J Thorac Oacol,2010,5(1):10-16.
  • 6Hinz S,Weikert S,Magheli A,et al.Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma[J].J Urol,2009,182(6):2920-5.
  • 7康凯夫,王晓蔚,陈小伍,车爱文,陈坚平.Bmi-1和EZH2在肝癌中的表达及其临床意义[J].临床与实验病理学杂志,2008,24(6):743-744. 被引量:9
  • 8Juan AH,Kumar RM,Marx JG,et al.Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells[J].Mol Cell,2009,36(1):61-74.
  • 9尚乐(摘译),张建中(校).多节族蛋白家族成员Bmi1和EZH2的过表达与肝癌细胞增殖和侵袭的生物学行为相关(英)[J].诊断病理学杂志,2008,15(6):509-509. 被引量:2
  • 10Fluge θ,Gravdal K,Carlsen E,et al.Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis[J].Br J Cancer,2009,101(8):1282-1289.

二级参考文献7

  • 1冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 2Gil J, Bernard D, Peters G. Role of polycomb group proteins in stem cell self-renewal and cancer [ J ]. DNA Cell Biol, 2005,24 (2) :117 -125.
  • 3Frank M, Raaphorst, Folkert J,et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease[J]. Am J Pathol, 2000,157(3) :709 -715.
  • 4Park I K, Qian D, Kiel M,et al. Bmi-1 is required for maintenance of aduh self-renewing haematopoietic stem cells [ J ]. Nature, 2003,423 (6937) : 302 - 305.
  • 5Park I K, Morrison S J, Clarke M F. Bmi I, stem cells, and senescenee regulation [ J ]. J Clin Invest,2004,113 ( 2 ) : 175 - 179.
  • 6van Lohuizen M, Verbeek S, Scheijen B,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by rovirus tagging [J]. Cell, 1991,65:737 - 752.
  • 7Jacobs J J L, Scheijen B, Voncken J W,et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF[ J]. Genes Dev, 1999,13:2678 - 2690,

共引文献8

同被引文献16

  • 1Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
  • 2Tejpar S,Shen L,Wang X,et al.Integrating biomarkers in colorectal cancer trials in the West and China[J].Nat Rev Clin Oncol,2015,12(9):553-560.
  • 3Reijm EA,Timmermans AM,Look MP,et al.High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer[J].Ann Oncol,2014,25(11):2185-2190.
  • 4Meng X,Huang Z,Wang R,et al.The prognostic role of EZH2expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy[J].Radiat Oncol,2014(9):188.
  • 5Fluge O,Gravdal K,Carlsen E,et al.Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis[J].Br J Cancer,2009,101(8):1282-1289.
  • 6Xu B,Abourbih S,Sircar K,et al.Enhancer of zeste homolog 2expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma:a comparative study and review of the literature[J].Arch Pathol Lab Med,2013,137(10):1326-1336.
  • 7Ciarapica R,Miele L,Giordano A,et al.Enhancer of zeste homolog 2(EZH2)in pediatric soft tissue sarcomas:first implications[J].BMC Med,2011(9):63.
  • 8Xiao Y.Enhancer of zeste homolog 2:A potential target for tumor therapy[J].Int J Biochem Cell Biol,2011,43(4):474-477.
  • 9Knudsen ES,Dervishaj O,Kleer CG,et al.EZH2 and ALDH1expression in ductal carcinoma in situ:complex association with recurrence and progression to invasive breast cancer[J].Cell Cycle,2013,12(13):2042-2050.
  • 10Au SL,Wong CC,Lee JM,et al.Enhancer of zeste homolog 2epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis[J].Hepatology,2012,56(2):622-631.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部